Byline: John Hill
UNIVERSITIES are meant to be places where people share and uncover information. Bearing that in mind, Inkspot Science says its data-sharing and analysis platform will hopefully be very much at home at the University of Sunderland.
Inkspot has developed a web-based platform which allows users to share data securely, carry out sophisticated analysis, and have access to flexible cloud computing. It was co-founded by former AstraZeneca and Cyprotex executive Professor David Leahy, and has been a plc since 2008.
Sunderland is the first major university to sign up with Inkspot, and will be collaborating over at least a three-year period.
Gateshead's Inkspot now also has a dedicated office in the university's pounds 8.5m science complex, where it will provide support to staff and students in areas such as pharmaceutical sciences and in drug design for fields such as bacterial resistance and transplantation.
Leahy said: "The Sunderland agreement is very important. It's everything we designed the platform for.
"We're keen to make a success of this, as it gives Inkspot an opportunity to better understand what a modern research university really needs. In the longer term we hope to roll it out to other universities as well."
Inkspot has been collaborating with global open source solutions firm Red Hat to fine-tune how it can service academic and research organisations.
It allows science and engineering companies to store and analyse data, run workflows and share their work with selected individuals, acting as a "scientific Facebook". …